LU85271A1 - Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von creme - Google Patents

Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von creme Download PDF

Info

Publication number
LU85271A1
LU85271A1 LU85271A LU85271A LU85271A1 LU 85271 A1 LU85271 A1 LU 85271A1 LU 85271 A LU85271 A LU 85271A LU 85271 A LU85271 A LU 85271A LU 85271 A1 LU85271 A1 LU 85271A1
Authority
LU
Luxembourg
Prior art keywords
bifonazole
optionally
diluent
imidazole
cream
Prior art date
Application number
LU85271A
Other languages
German (de)
English (en)
Inventor
Karlheinz Adams
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of LU85271A1 publication Critical patent/LU85271A1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
LU85271A 1983-03-30 1984-03-28 Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von creme LU85271A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833311701 DE3311701A1 (de) 1983-03-30 1983-03-30 Antimykotische mittel mit hoher wirkstoff-freisetzung in form von creme
DE3311701 1983-03-30

Publications (1)

Publication Number Publication Date
LU85271A1 true LU85271A1 (de) 1984-11-14

Family

ID=6195162

Family Applications (1)

Application Number Title Priority Date Filing Date
LU85271A LU85271A1 (de) 1983-03-30 1984-03-28 Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von creme

Country Status (19)

Country Link
JP (1) JPS59184106A (sv)
KR (1) KR840008284A (sv)
AU (1) AU564956B2 (sv)
BE (1) BE899278A (sv)
CA (1) CA1212327A (sv)
CH (1) CH660126A5 (sv)
CY (1) CY1358A (sv)
DE (1) DE3311701A1 (sv)
ES (3) ES8503947A1 (sv)
FR (1) FR2543435B1 (sv)
GB (1) GB2137091B (sv)
GR (1) GR81485B (sv)
IT (1) IT1173761B (sv)
KE (1) KE3704A (sv)
LU (1) LU85271A1 (sv)
PH (1) PH20420A (sv)
PT (1) PT78313B (sv)
SE (1) SE8401748L (sv)
ZA (1) ZA842337B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
AU4399793A (en) * 1992-06-08 1994-01-04 Schering-Plough Healthcare Products, Inc. Stable imidazole anti-fungal powder compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2461406C2 (de) * 1974-12-24 1984-06-14 Bayer Ag, 5090 Leverkusen Azolyl-(1)-methane und deren Salze, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE3045914A1 (de) * 1980-12-05 1982-07-22 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3045915A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3045913A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung
DE3106635A1 (de) * 1981-02-23 1982-09-09 Bayer Ag Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von stiften

Also Published As

Publication number Publication date
ES530846A0 (es) 1985-04-16
KR840008284A (ko) 1984-12-14
CH660126A5 (de) 1987-03-31
SE8401748D0 (sv) 1984-03-29
JPS59184106A (ja) 1984-10-19
SE8401748L (sv) 1984-10-01
ES539289A0 (es) 1985-11-16
BE899278A (fr) 1984-10-01
ES8601693A1 (es) 1985-11-16
FR2543435A1 (fr) 1984-10-05
KE3704A (en) 1987-03-27
ZA842337B (en) 1984-11-28
FR2543435B1 (fr) 1988-06-17
PH20420A (en) 1987-01-05
GB2137091B (en) 1986-10-01
ES8503947A1 (es) 1985-04-16
PT78313A (en) 1984-04-01
AU564956B2 (en) 1987-09-03
CY1358A (en) 1987-08-07
IT8420303A0 (it) 1984-03-29
GB2137091A (en) 1984-10-03
IT1173761B (it) 1987-06-24
CA1212327A (en) 1986-10-07
GR81485B (sv) 1984-12-11
ES8601692A1 (es) 1985-11-16
PT78313B (en) 1986-06-02
ES539290A0 (es) 1985-11-16
AU2623684A (en) 1984-10-04
GB8408067D0 (en) 1984-05-10
DE3311701A1 (de) 1984-10-04

Similar Documents

Publication Publication Date Title
EP0058887B1 (de) Antimykotische Mittel mit hoher Wirkstoff-Freisetzung in Form von Stiften
EP0524548B1 (de) Antimikrobiell wirksame Gemische
EP0054205B1 (de) Antimykotische Mittel in Emulsionsform mit hoher Wirkstoff-Freisetzung
EP0045424B1 (de) Gegen Zecken wirksame Pour-on-Formulierungen
DE3035135C2 (sv)
EP0055397B1 (de) Antimykotische Mittel mit hoher Wirkstoff-Freisetzung in Form von elastischen Flüssig-Pflastern
DE2614841C2 (sv)
DE3522853C2 (de) Haarkosmetikumzusammensetzung
EP0055396B1 (de) Antimykotische Mittel mit hoher Wirkstoff-Freisetzung in Form von elastischen Flüssig-Pflastern
DD203464A5 (de) Verfahren zur herstellung einer verbesserten oel-in-wasser-formulierung von 9-(2-hydroxy-aethoxymethyl)-guanin fuer lokale anwendung
EP0804150B1 (de) Fettsäurederivate enthaltende lotionen
EP3733157B1 (de) Zusammensetzung enthaltend mindestens ein ceramid, mindestens eine sphingoidbase und triethylcitrat
DE2755224A1 (de) Schmerzen und entzuendungen linderndes mittel zur oertlichen anwendung
EP0315912B1 (de) Sebosuppressive Zubereitungen
LU85271A1 (de) Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von creme
DE3323833A1 (de) Etofenamat-zubereitung
CH647948A5 (de) Mittel fuer die aeusserliche behandlung von wunden oder suppositorien fuer die behandlung von wunden bei menschen und tieren.
EP0113009A2 (de) Antimykotische Mittel mit hoher Wirkstoff-Freisetzung in Form von Gelsystemen
CH660304A5 (de) Antimykotische mittel mit hoher wirkstoff-freisetzung enthaltend bifonazol in form von loesung und spray.
EP0835100B1 (de) Topische aciclovir-zubereitung
DE3402645A1 (de) Kosmetische mittel, welche natuerliche essenzen und benzylidenkampferderivate enthalten
EP0383162A1 (de) Verwendung einer Wirkstoffkombination zur Behandlung rheumatischer Erkrankungen
EP0128459A2 (de) Antimykotische Mittel für einmalige gynäkologische Behandlung
EP0130516A2 (de) Etofenamat-Zubereitung
DE3243544A1 (de) Antimykotische mittel fuer einmalige gynaekologische behandlung